发明授权
- 专利标题： Process for the preparation of amorphous imatinib mesylate
- 专利标题（中）： 制备无定形伊马替尼甲磺酸盐的方法
-
申请号： US14059971申请日： 2013-10-22
-
公开(公告)号： US09439903B2公开(公告)日： 2016-09-13
- 发明人: Shriprakash Dhar Dwivedi , Kumar Kamlesh Singh , Ganpant Dan Shimbu Charan , Chetan Jayantibhai Vasava
- 申请人： CADILA HEALTHCARE LIMITED
- 申请人地址： IN Ahmedabad
- 专利权人： Cadila Healthcare Limited
- 当前专利权人： Cadila Healthcare Limited
- 当前专利权人地址： IN Ahmedabad
- 代理机构： Ladas & Parry LLP
- 优先权： IN3100/MUM/2012 20121025
- 主分类号： A61K31/506
- IPC分类号： A61K31/506 ; A61K45/06 ; C07D403/00
摘要：
The field of the invention relates to a process for the preparation of amorphous imatinib mesylate. In particular, the invention relates to a process for the preparation of stable amorphous imatinib mesylate. More particularly, the invention relates to pharmaceutical compositions that includes the stable amorphous imatinib messylate together along with its excipients.
公开/授权文献
信息查询
IPC分类:
